cdmo.directory
← Compare landing

Hillgene vs Viralgen

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryHillgeneViralgen
SummaryHillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Regulatory Affairs
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Analytical Method Development & Validation
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
Data not yet provided.
Locations
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
  • EMA · Identifier: AEMPS/EMA certified

Find similar companies

Hillgene alternatives · Viralgen alternatives

Markdown mirror: /compare/hillgene/viralgen.md